Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01591
|
|||||
| Drug Name |
Mycophenolic acid glucuronide
|
|||||
| Synonyms |
MPAG; Mycophenolic acid glucosiduronate; mycophenolic acid glucuronide; UNII-54TS5J9T0K; 54TS5J9T0K; AC1O5XMV; BYFGTSAYQQIUCN-HGIHDBQLSA-N; Mycophenolic Acid ; A-D-Glucuronide; ZINC13550000; (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[[5-[(E)-6-hydroxy-3-methyl-6-oxohex-2-enyl]-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-4-yl]oxy]oxane-2-carboxylic acid; 5-[(2E)-5-Carboxy-3-methyl-2-penten-1-yl]-1,3-dihydro-6-methoxy-7-methyl-3-oxo-4-isobenzofuranyl
|
|||||
| Indication | Lung transplantation [ICD11: QB63.2] | Phase 1 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C23H28O12
|
|||||
| Canonical SMILES |
CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)OC3C(C(C(C(O3)C(=O)O)O)O)O
|
|||||
| InChI |
InChI=1S/C23H28O12/c1-9(5-7-13(24)25)4-6-11-18(32-3)10(2)12-8-33-22(31)14(12)19(11)34-23-17(28)15(26)16(27)20(35-23)21(29)30/h4,15-17,20,23,26-28H,5-8H2,1-3H3,(H,24,25)(H,29,30)/b9-4+/t15-,16-,17+,20-,23+/m0/s1
|
|||||
| InChIKey |
BYFGTSAYQQIUCN-HGIHDBQLSA-N
|
|||||
| CAS Number |
CAS 31528-44-6
|
|||||
| Pharmaceutical Properties | Molecular Weight | 496.5 | Topological Polar Surface Area | 189 | ||
| Heavy Atom Count | 35 | Rotatable Bond Count | 9 | |||
| Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 12 | |||
| XLogP |
1.1
|
|||||
| PubChem CID | ||||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
| References | ||||||
| 1 | ClinicalTrials.gov (NCT01014442) A Study of Mycophenolate Mofetil (CellCept) in Lung Transplant Recipients | |||||
| 2 | Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients. Ther Drug Monit. 2008 Oct;30(5):559-64. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.